Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for ovulation and pregnancy in polycystic ovarian syndrome
IRCT20171031037130N2Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of oxytocin in polycystic ovary syndrome (PCOS), sponsored by Iran University of Medical Sciences. Started Oct 2017; status: completed.
02
Drugs
oxytocin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20171031037130N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171031037130N2.